Q32 Bio Files Annual Report for FY 2025

Ticker: QTTB · Form: ARS · Filed: Apr 30, 2026 · CIK: 0001661998

Q32 Bio Inc. ARS Filing Summary
FieldDetail
CompanyQ32 Bio Inc. (QTTB)
Form TypeARS
Filed DateApr 30, 2026
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: annual-report, sec-filing, pharmaceuticals

TL;DR

Q32 Bio filed its 2025 ARS. Check it for performance details.

AI Summary

Q32 Bio Inc. filed its Annual Report to Security Holders (ARS) on April 30, 2026, for the period ending December 31, 2025. The company, headquartered in Waltham, MA, is involved in the pharmaceutical preparations industry, specifically within Life Sciences.

Why It Matters

This filing provides shareholders with an overview of the company's performance and financial standing for the fiscal year 2025.

Risk Assessment

Risk Level: low — This is a routine annual report filing and does not contain new material events or financial distress indicators.

Key Numbers

  • 4471494 — PDF Size (Size of the primary ARS document)
  • 6159077 — Text File Size (Size of the complete submission text file)

Key Players & Entities

  • Q32 Bio Inc. (company) — Filer
  • 0001661998 (company) — CIK
  • 2026-04-30 (date) — Filing Date
  • 2025-12-31 (date) — Period of Report
  • 830 WINTER STREET WALTHAM MA 02451 (address) — Mailing and Business Address

FAQ

What is the CIK number for Q32 Bio Inc.?

The CIK number for Q32 Bio Inc. is 0001661998.

On what date was this ARS filing accepted by the SEC?

This ARS filing was accepted on 2026-04-30.

What period does this Annual Report to Security Holders cover?

This report covers the period ending 2025-12-31.

What is the business address of Q32 Bio Inc.?

The business address of Q32 Bio Inc. is 830 WINTER STREET WALTHAM MA 02451.

What is the SIC code for Q32 Bio Inc.?

The SIC code for Q32 Bio Inc. is 2834, which falls under Pharmaceutical Preparations (CF Office: 03 Life Sciences).

Filing Details

This Form ARS (Form ARS) was filed with the SEC on April 30, 2026 regarding Q32 Bio Inc. (QTTB).

View full filing on EDGAR

View Full Filing

View this ARS filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.